<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-0eba195e=""><div class="content_outer_container" data-v-0eba195e=""><div class="share_preview_container" data-v-0eba195e=""><div class="dialog_list" data-v-0eba195e=""><div class="dialog_item" data-v-0eba195e=""><div class="dialog_question fir_dialog_question" data-v-0eba195e=""><div class="question_con" data-v-0eba195e=""><h1 class="fir_question_content" data-v-0eba195e="">
                                    How did TAK's Q4 2024 forecast compare to past performance?
                                </h1> <div class="user_slot" data-v-0eba195e=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-0eba195e=""> <span class="user_desction" data-v-0eba195e="">
                                        
                                        4/11/2025 07:34pm
                                    </span></div></div></div> <div class="seo-text-answer" data-v-0eba195e="">Takeda Pharmaceutical's (TAK) Q4 2024 forecasted performance was not provided in the available data. However, the actual performance for Q4 2023 showed a net income of $234.54 million. This figure can be used as a benchmark to assess the company's financial performance against future forecasts.

</div> <div class="dialog_answer" data-v-0eba195e=""><div class="dialog_content" data-v-0eba195e=""><div class="answer_content" data-v-0eba195e=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-261d488f=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-261d488f=""> <div class="recommend-part" data-v-7790c618="" data-v-261d488f=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai,aj,ak,al,am,an,ao,ap,aq,ar,as,at,au,av,aw,ax,ay,az,aA,aB,aC,aD,aE,aF,aG,aH,aI){return {layout:"default",data:[{noData:c,currentQuestion:g,textDescription:K,comeFrom:"AInvestShareLink",events:[],answerSource:n}],fetch:{},error:o,state:{sharePreviewModule:{loadJgySuccess:e,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:p,agent_id:a,output_media_info:[],task_id:a,language:a,source:n,cache_builder:a,reply_action:"Answer",execute_mode:A,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"How did TAK's Q4 2024 forecast compare to past performance?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"How did TAK's Q4 2024 forecast compare to past performance?\",\"user_id\":\"dp12899424\",\"user_name\":\"\",\"trace_id\":\"c81954a6-ceb2-4792-ad41-61b0ab0599ba\",\"session_id\":\"c81954a6-ceb2-4792-ad41-61b0ab0599ba\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:"query_data",query_type:B,text:"1 results found:\n|stock code|stock name|Last Price|Last Change|Estimate EPS[20241231]|Net Income[20231231]|\n|---|---|---|---|---|---|\n|TAK|Takeda Pharmaceutical|$13.87|-3.28%||$234.54 million|\n",query_data:{number:L,title:C,query_type:B,condition:a,model_sql:M,data_ext_params:{merge_repeat:c,expand_index:b,data_add:p,add_index:e}}}],answer_chain_name:N,agent_mode:O,native_answer:a,come_from:a,text_answer:K,trace_id:i,cost:19280,event_names:a,question:g,fallback_type:P,input_type:Q,fall_back_reason:{fall_back_type:P,risk_detail:{matched_words:[]}},session_id:i,first_return_cost:2666,cache_type:a,question_id:i,transfer_question:g,signal_type:"ON_COMPLETE",start_time:R,remote_svc:n,slots:[],answer_type:A,user_id:x,skill_name:D},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:i,session_id:i,user_id:x,question:g,source:n,raw_question:g,version:"3.4.1",action_name:D,nlu:{entity:[{type:S,value:T,market:E}]},deep_research:c,deep_thinking:c,agent_mode:O},extra:{}},{answer_path:q,section:{id:r,info_texts:["Thinking"],show_type:s,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"begin"},logs:[],extra:{is_deep_research:c,deep_thinking:c}},{answer_path:q,section:{id:r,info_texts:["Querying Stock: TAK Latest Report Period"],show_type:s,choice:[],result_page:{},tag_info_list:[],is_last:b,status:U},logs:[],extra:{action:V,action_input:"TAK Latest Report Period",thought:"The user wants to compare TAK's Q4 2024 forecast performance with its actual past performance. I should focus on the latest report period to reason the corresponding fiscal quarter to obtain the historical performance reference. I will use FinQuery for the data mentioned above."}},{answer_path:d,section:{id:k,info_texts:[],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:q,section:{id:r,info_texts:["Querying Stock: TAK Forecasted Performance in Fiscal 2024Q4, Actual Performance in Fiscal 2023Q4"],show_type:s,choice:[],result_page:{},tag_info_list:[],is_last:b,status:U},logs:[],extra:{action:V,action_input:C,thought:"I have obtained the latest report period of TAK is 2025Q3. Now I will use FinQuery to obtain the forecast and actual performance of TAK in Fiscal 2024Q4; use FinQuery to obtain the historical performance of TAK in Fiscal 2023Q4."}},{answer_path:d,section:{id:k,info_texts:[],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:k,info_texts:[],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:q,section:{id:r,info_texts:["Generating Answer"],show_type:s,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"ongoing"},logs:[],extra:{}},{answer_path:d,section:{id:l,info_texts:[],show_type:t,voice_txt:"T",text_answer:W,rich_text:W,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:2000,info_texts:[],show_type:t,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{title:C,query_type:B,trace_data:a,index:L,model_sql:M,data_ext_params:{merge_repeat:c,expand_index:b,data_add:p,add_index:e},jump_type:"data_query"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:l,info_texts:[],show_type:t,voice_txt:". This",text_answer:X,rich_text:X,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:k,info_texts:[],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:Y,market_id:E,name:Z,domain:S},pos:e,section_id:l,txt:Z,jump_type:"pos_fenshi"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:k,info_texts:[],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:k,info_texts:[],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:l,info_texts:[],show_type:t,voice_txt:"\n",text_answer:_,rich_text:_,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:l,info_texts:[],show_type:$,choice:[],result_page:{components:[{category:aa,puuid:ab,request_config:[{related_name:ac,source_type:F}],show_type:ad,tag:"Analyst Estimate Earnings",uuid:ae,title_config:{config:{display:c,display2:c,txt_style:e,type:af,url:a},data:{h1:a,h2:a},show_type:ag}}],global:{interface_request_list:[],lowcode_json:{stack:c,visible:b,childLimit:ah,label:y,type:ai,leaf:c,animate:[],version:aj,script:[],props:{test:a},path:ak,style:{"background-color":a,"box-shadow":al,color:a,width:h,"min-height":am,position:z,height:h},isMaterial:c,id:y,needTheme:c,hasEditor:c,packed:c,events:[],child:[{stack:c,visible:b,childLimit:e,label:"财报",type:an,leaf:b,version:"0.0.1",animate:[],url:G,componentUuid:ae,script:[{name:"earnings",id:65539,content:"return {\r\n  mounted () {\r\n    window.__oversea_ainvest__ = {\r\n      ENV: \"production\"\r\n    }\r\n  }\r\n}"}],props:{title:"Earnings"},path:G,meta:{js_url:G},style:{"background-color":a,padding:"0",color:a,display:ao,width:h,position:z,height:h},isMaterial:b,_id:ap,id:an,hasEditor:b,packed:c,events:[],isSetDefaultValue:b}]},lowcode_type:aq,urp_static_data:[{name:ac,value:{columns:[{index_name:ar,key:ar,type:f},{index_name:as,key:as,type:f}],dataSize:p,datas:[{code:Y,market_code:E}]}},{name:"advance_custom_visual",value:{columns:[{index_name:at,key:at,type:f},{index_name:au,key:au,type:f},{index_name:av,key:av,type:f}],dataSize:p,datas:[{stock_code:T,start_date:"2024-01-01",end_date:"2024-12-31"}]}}]},page:{layout:{layout_data:"[{\"uuid\":\"gyyEarnings\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:H,uuid:ab,voice_txt:a}},tag_info_list:[],is_last:c,uuid:"3d3b1333-fdb0-4a24-ae77-6741a5a1e0cc"},logs:[],extra:{}},{answer_path:d,section:{id:l,info_texts:[],show_type:t,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:q,section:{id:r,info_texts:["Completed"],show_type:s,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:$,choice:[{display_text:u,query_text:u,trace_info:{item_id:"27bb546a235ebc81c4861d453fc9ac6f",item_type:m,item_name:u,rec_info:aw}},{display_text:v,query_text:v,trace_info:{item_id:"ec1766b928d144af3b681894ec7f4f3b",item_type:m,item_name:v,rec_info:ax}},{display_text:w,query_text:w,trace_info:{item_id:"cab9f156917716fb3fe80e029b80013a",item_type:m,item_name:w,rec_info:ay}}],result_page:{components:[{show_type:ad,title_config:{show_type:ag,data:{h1:a,h2:a},config:{display:c,txt_style:e,type:af,display2:c,url:a}},request_config:[{source_type:F,related_name:az}],puuid:I,tag:a,category:aa,uuid:aA}],global:{urp_static_data:[{name:az,value:{status_code:e,columns:[{type:f,index_name:aB,key:aB},{type:f,index_name:aC,key:aC},{type:f,index_name:aD,key:aD},{type:f,index_name:aE,key:aE},{type:f,index_name:aF,key:aF}],datas:[{send_text:u,item_type:m,rec_info:aw,display_text:u,rec_reason:a},{send_text:v,item_type:m,rec_info:ax,display_text:v,rec_reason:a},{send_text:w,item_type:m,rec_info:ay,display_text:w,rec_reason:a}],dataSize:F,status_msg:a}}],lowcode_type:aq,interface_request_list:[],lowcode_json:{stack:c,visible:b,childLimit:ah,label:y,type:ai,leaf:c,animate:[],version:aj,script:[],props:[],path:ak,isTransparent:b,style:{"background-color":a,"box-shadow":al,color:a,width:h,"min-height":am,position:z,height:h},isMaterial:c,id:y,needTheme:c,hasEditor:c,packed:c,events:[],child:[{readmeUrl:"https:",stack:c,visible:b,customStyle:a,childLimit:e,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:b,version:"1.12.0",animate:[],url:J,componentUuid:aA,script:[{name:aG,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:b,renderType:"blue"},path:J,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:J},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:ao,width:h,position:z,height:h},isMaterial:b,_id:ap,id:aG,hasEditor:b,packed:c,events:[],isSetDefaultValue:b}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:H,voice_txt:a,tracking_info:{},uuid:I},order:{is_auto:c,render_for:H,chart_type:"command",puuid:I}},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1005,info_texts:[],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{action_name:D,with_paid_index:c,no_refresh_answer:c,answer_source:{agent_id:a,agent_name:a,execute_mode:A,answer_chain_name:N},is_deep_research:c,deep_thinking:c,create_time:1744371270645},is_last:b}],questionItem:{data:{qStr:g,encodeFlag:c,imageData:o,docsData:[],quoteData:o},tplType:"question"},events:aH,agentId:a,param:{entity_info:{},add_info:{ori_question:g},event_list:aH,client_ip:a,question:g,user_id:x,user_name:a,trace_id:i,session_id:i,source:n,input_type:Q}}],userId:x,userName:a,startTime:R,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:o,endSignal:c,theme:"white",showTracePopup:c,traceListData:[],chatTraceTargetIndex:e,traceTableData:o,showMask:c}},serverRendered:b,routePath:"\u002Faime\u002Fshare\u002Fhow-did-taks-q4-2024-forecast-compare-to-past-performance-52761c\u002F",config:{_app:{basePath:aI,assetsPath:aI,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",true,false,"other\u002FopenAnswer",0,"STR","How did TAK's Q4 2024 forecast compare to past performance?","auto","c81954a6-ceb2-4792-ad41-61b0ab0599ba","signal",999,2001,"llm_generated","ths_ainvest_lite_web",null,1,"progress\u002Fsearching_for",1000,"searching_for","rich_text","Has TAK's stock price shown a consistent upward trend?","How did analysts rate TAK's Q4 2024 earnings?","What are the short-term price targets for TAK?","dp12899424","root","relative","agent","intusstock","TAK Forecasted Performance in Fiscal 2024Q4, Actual Performance in Fiscal 2023Q4","review stocks","169",3,"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002Fearnings\u002F0.0.1\u002Fearnings@0.0.1index.js","aigc","39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","Takeda Pharmaceutical's (TAK) Q4 2024 forecasted performance was not provided in the available data. However, the actual performance for Q4 2023 showed a net income of $234.54 million. This figure can be used as a benchmark to assess the company's financial performance against future forecasts.\n\n",2,"select   stock_code,   estimate_eps from   ustock_fin_forecast where   fiscal_date = date('2024y4q')   and stock_code = 'TAK.N' intersect select   stock_code,   net_income from   ustock_fin_data where   fiscal_date = date('2023y4q')   and stock_code = 'TAK.N'","agent_common_v2\nagent-summary","normal_agent","NONE","typewrite",1744371251365,"stock","TAK.N","thinking","Querying Stock","Takeda Pharmaceutical's (TAK) Q4 2024 forecasted performance was not provided in the available data. However, the actual performance for Q4 2023 showed a net income of $234.54 million[^2]",". This figure can be used as a benchmark to assess the company's financial performance against future forecasts.\n\n","TAK","Takeda Pharmaceutical","\n``` visual\n{\"uuid\":\"3d3b1333-fdb0-4a24-ae77-6741a5a1e0cc\"}\n```","result_page","custom","39192","code_entity","lowcode","gyyEarnings","1","title1",9999,"thslc\u002Fthslc-common-container","1.0.1","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js","0px 0px 0px","100%","iwencai\u002Fearnings","block",19,"shunda","market_code","code","stock_code","end_date","start_date","2+679_496_21_554+0+0+c81954a6-ceb2-4792-ad41-61b0ab0599ba+27bb546a235ebc81c4861d453fc9ac6f+llm_generated+aimeTagAnalysis+0+0.10115601867437363+1","2+679_496_21_554+0+0+c81954a6-ceb2-4792-ad41-61b0ab0599ba+ec1766b928d144af3b681894ec7f4f3b+llm_generated+aimeTagAnalysis+0+0.09437897056341171+2","2+679_496_21_554+0+0+c81954a6-ceb2-4792-ad41-61b0ab0599ba+cab9f156917716fb3fe80e029b80013a+llm_generated+aimeTagAnalysis+0+0.08507170528173447+3","recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","iwencai\u002FrecommendList0326",Array(0),"\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/b929a16.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/28ccbec.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/d9802b5.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/2077034.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/1e0f8d6.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7a5f495.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/921844b.js" defer=""></script>